| Literature DB >> 25126308 |
Quang Nguyen1, Joann Dominguez2, Loida Nguyen3, Nageshwara Gullapalli4.
Abstract
Hypertension is a significant and costly public health problem. It is a major, but modifiable contributor for the development of cardiovascular disease. Randomized controlled trials have shown that controlling hypertension reduces the risk of stroke, coronary artery disease, congestive heart failure, end-stage renal disease, peripheral vascular disease, as well as overall mortality. The risk of developing these hypertension-related complications is continuous, starting at a blood pressure level as low as 115/75 mm Hg. Despite the inherent health risks associated with uncontrolled hypertension, elevated blood pressure remains inadequately treated in the majority of patients. This article reviews guidelines for optimal evaluation of hypertension and current therapeutic options available to combat this common yet pervasive disease.Entities:
Year: 2010 PMID: 25126308 PMCID: PMC4106550
Source DB: PubMed Journal: Am Health Drug Benefits ISSN: 1942-2962